Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for DBV Technologies S.A.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 8:56 pm Purchase | 2023-12-31 | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Venrock Healthcare Capital Partners II, L.P. | 965,466 9.990% | 25,118 (+2.67%) | Filing |
| 2023-02-14 4:31 pm Purchase | 2022-12-31 | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Venrock Healthcare Capital Partners II, L.P. | 940,348 9.990% | 65 (+0.01%) | Filing |
| 2022-06-23 06:02 am Purchase | 2022-06-13 | 13G | DBV TECHNOLOGIES S.A. AMERICAN DBVT | Venrock Healthcare Capital Partners II, L.P. | 940,283 9.900% | 940,283 (New Position) | Filing |